Clinical and surgical implications of EGFR mutations in non-small cell lung cancer

Clinical and surgical implications of EGFR mutations in non-small cell lung cancer

Bibliographic Details
Main Authors:	M. Yoon, C. Chen
Format:	Article
Language:	English
Published:	Ubiquity Press 2016-08-01
Series:	Annals of Global Health
Online Access:	https://annalsofglobalhealth.org/articles/1120

Similar Items

Clinical Features of EGFR Double Mutation in Non-small Cell Lung Cancer
by: Mengyao WANG, et al.
Published: (2018-08-01)

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
by: Ding-Yu Rao, et al.
Published: (2023-04-01)

Detecting EGFR mutations in patients with non-small cell lung cancer
by: Hammoudeh ZA, et al.
Published: (2018-10-01)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
by: Tomoaki Sonoda, et al.
Published: (2018-01-01)

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
by: Isa Mambetsariev, et al.
Published: (2022-03-01)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
by: Azhar Ali, et al.
Published: (2018-03-01)

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
by: Tereza Vaclova, et al.
Published: (2021-03-01)

Advances in immunotherapy of advanced non-small cell lung cancer with EGFR mutation
by: HUANG Huayan, et al.
Published: (2023-05-01)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer
by: Yaoyao LIU, et al.
Published: (2023-12-01)

Non-small-cell lung cancer: how to manage EGFR-mutated disease
by: Federica Pecci, et al.
Published: (2022-08-01)

Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
by: Masaharu Nomura, et al.
Published: (2007-04-01)

The Role of <i>TP53</i> Mutations in <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
by: Matteo Canale, et al.
Published: (2022-02-01)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
by: Christi M. J. Steendam, et al.
Published: (2020-10-01)

Clinical Features of EGFR Mutation Negative in Patients  with Non-small Cell Lung Cancer and Brain Metastases
by: Yixiang ZHU, et al.
Published: (2021-01-01)

Clinical Analysis of Icotinib on Beneficiary of  Advanced Non-small Cell Lung Cancer with EGFR Common Mutation
by: Xiaowen JIANG, et al.
Published: (2016-04-01)

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations
by: Ping-Chih Hsu, et al.
Published: (2022-10-01)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
by: Gao X, et al.
Published: (2019-11-01)

Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer
by: Mio Mori, et al.
Published: (2019-04-01)

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
by: Thang Thanh Phan, et al.
Published: (2019-01-01)

Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
by: Drew F. K. Williamson, et al.
Published: (2022-01-01)

Transcriptional profiling of non-small cell lung cancer cells with activating EGFR somatic mutations.
by: Kuicheon Choi, et al.
Published: (2007-11-01)

Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations
by: Alfredo Addeo
Published: (2022-06-01)

Application of Third-generation TKIs in EGFR-mutated Non-small Cell Lung Cancer
by: XU Wenwen, et al.
Published: (2021-12-01)

Novel therapeutic strategies for targeting EGFR mutated non-small cell lung cancer
by: Drobnitzky, N
Published: (2017)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
by: Karan Seegobin, et al.
Published: (2021-12-01)

Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer
by: Danjing LUO, et al.
Published: (2017-06-01)

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
by: Jonathan R. Thompson, et al.
Published: (2016-10-01)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
by: Fang S, et al.
Published: (2014-09-01)

Research Progress of EGFR T790M Mutation in Non-small Cell Lung Cancer
by: HOU Ran, et al.
Published: (2020-06-01)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
by: Viteri Santiago, et al.
Published: (2010-12-01)

Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation.
by: Min-Sun Cho, et al.
Published: (2020-01-01)

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
by: Pauline Gilson, et al.
Published: (2021-05-01)

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
by: Akihiro Yoshimura, et al.
Published: (2019-03-01)

Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
by: J. Chantharasamee, et al.
Published: (2019-07-01)

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
by: Kamal Eltayeb, et al.
Published: (2022-01-01)

Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
by: Jung Soo Kim, et al.
Published: (2017-01-01)

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer
by: Shigetoshi Nishihara, et al.
Published: (2022-11-01)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
by: Marco Galvez‐Nino, et al.
Published: (2023-01-01)

EGFR‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
by: Thang Thanh Phan, et al.
Published: (2022-08-01)